ArticlePregnancy (Hoboken, N.J.)2025
Severe acute respiratory syndrome coronavirus 2 and preterm birth, clinical implications-A register-based cohort study from Sweden.
Article in Pregnancy (Hoboken, N.J.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection during pregnancy is associated with an increased risk of preterm birth (PTB). The aim of the study was to investigate the effect of timing of SARS-CoV-2 infection during pregnancy on PTB risk and whether the risk is related to the interval from infection onset. We also studied whether the association is driven primarily by spontaneous or iatrogenic PTB, as well as to what extent disease severity, viral variant, background characteristics, and vaccination status affect the risk for PTB. Material and methods: This is a Swedish population-based register study including all singleton pregnancies registered in the Swedish Pregnancy Register with estimated date of birth between March 1, 2020 and May 31, 2022 ( Results: There was a significant ( Conclusions: Pregnant women are at particularly high risk of PTB within 14 days after a SARS-CoV-2 infection, and should be counselled on PTB symptoms to ensure that they seek medical care without delay. The increased PTB risk is partly mitigated by vaccination against SARS-CoV-2.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.